Forte Biosciences, Inc.FBRXNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank90
3Y CAGR+94.9%
5Y CAGR+33.0%
Year-over-Year Change
Research and development spending
3Y CAGR
+94.9%/yr
vs -42.3%/yr prior
5Y CAGR
+33.0%/yr
Recent acceleration
Acceleration
+137.2pp
Accelerating
Percentile
P90
Near historical high
vs 5Y Ago
4.2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $41.44M | +95.5% |
| 2024 | $21.19M | -3.1% |
| 2023 | $21.86M | +290.8% |
| 2022 | $5.59M | -59.6% |
| 2021 | $13.85M | +39.2% |
| 2020 | $9.95M | +272.2% |
| 2019 | $2.67M | -94.7% |
| 2018 | $50.45M | +73.3% |
| 2017 | $29.11M | +7.0% |
| 2016 | $27.22M | - |